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LETTERS TO THE EDCTOR 
aminoacid sequences in common which are thought 
to bind hormones to specific sequences of DNA and 
modify the gene transcription (Beato, 1989). The 
complex formed by the binding of a steroid with a 
receptor is translocated into the cell nucleus where 
it binds to DNA and influences the expression of 
genes So the activation in depression of the HPA 
axis involves various steps in producing excess Cor-
tisol and then inducing genomic change. The block-
ade at each one of them is being targeted to an-
tagonise the effects of stressful life events in pro-
ducing depression or in the treatment of depression. 
The therapeutic potential of antiglucocorticoid drugs 
especially type II receptor antagonists and steroid 
synthesis inhibitors have been explored with encour-
aging results in patients with mood disorders 
(Mitchell & O'Keanne, 1998). 
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TREATMENT BY IMIPRAMINE OF DEAFNES8 
AND DEPRESSION 
Sir, 
I would like to share one of my experience 
while treating a patient suffering from major depres-
sion with deafness. 
Mr. PCJ aged about 44 years, a cterk in NCC 
came to consult in June 97 with one year history of 
decreased interest in family, work & social activi-
ties, sleep and appetite. Interview was difficult as 
he was hard of hearing from both ears. With what-
ever communication possible by shouting at his right 
ear, he was found to be depressed, had ideas of 
hopelessness, worthlessness & a misfit in the 
present set up. He occasionally had ideas of end-
ing his life. 
He was prescribed Imipramine 75 mg per 
day, alprazolam 0.5 mg twice daily and 
advised to see an ENT specialist. He came back 
after 20 days with a relative and treatment records 
of his deafness. He had bilateral hearing impair-
ment for last 15 years, more marked on the left side. 
Clinically he was diagnosed as having "healed oti-
tis media with adhesive otitis media left". Audiogram 
revealed that patient had severe degree of conduc-
tive type of hearing loss in both ears more marked 
on left side. He was referred to neurosurgeon who 
advised CT scan head which was not done. 
Dejected Mr. PCJ came back having lost all 
hopes of hearing again. Meanwhile, dosage of imi-
pramine was subsequently increased to 125 mg per 
day. Over a period of few weeks his depression 
started lifting up. After 8-10 weeks when he came 
for review I was surprised to know that he could 
hear from both the ears. Hearing improved to the 
extent that he could converse on phone, could sense 
boiling of water from a distance of 3-4 feet. 
Weather this deafness was present to a 
minimum extent and got increased with 
depression or there was any relationship between 
the two cannot be commented upon with any 
certainty but what is sure that the deafness 
improved with imipramine. 
May be this experience of mine, stimulates 
few to explore the role of imipramine in treating 
such type of deafness? 
V.K. SRIVASTAVA, Psychiatrist, Mental Hospital, 
Bareilly. 243 005 (UP). 
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